Off Label Promotion

Marcus Baram

Pfizer Rapamune Lawsuit: Pharma Giant's Subsidiary Accused Of Targeting 'High-Risk' Black Patients For Unapproved Use Of Drug

HuffingtonPost.com | Marcus Baram | Posted 05.25.2011

Scroll down for the complaint This story has been updated In a stunning whistleblower lawsuit, the world's largest pharmaceutical company is being s...

The Worst Drug Company Marketing Techniques: Kickbacks And Fraud (PHOTOS, POLL)

Posted 05.25.2011

The Huffington Post recently learned that pharmaceutical industry insiders are expecting the health care reform legislation agreed to between the Whit...

Big Pharma's Crime Spree: Drug Makers Pushing Products For Unapproved Uses

Bloomberg | David Evans | Posted 05.25.2011

Pfizer and Lilly lead a parade of U.S. companies that have paid $7 billion in penalties after promoting drugs for uses not approved by the FDA. This u...

Eli Lilly's Zyprexa Fraud: Drug Company

The Huffington Post | Ryan McCarthy | Posted 05.25.2011

Drug companies are notorious for their relentless marketing. But, Eli Lilly, the century-old pharmaceutical giant, has taken things several steps fur...